1. Home
  2. ICUI vs GFF Comparison

ICUI vs GFF Comparison

Compare ICUI & GFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUI
  • GFF
  • Stock Information
  • Founded
  • ICUI 1984
  • GFF 1959
  • Country
  • ICUI United States
  • GFF United States
  • Employees
  • ICUI N/A
  • GFF N/A
  • Industry
  • ICUI Medical/Dental Instruments
  • GFF Building Products
  • Sector
  • ICUI Health Care
  • GFF Industrials
  • Exchange
  • ICUI Nasdaq
  • GFF Nasdaq
  • Market Cap
  • ICUI 3.0B
  • GFF 3.2B
  • IPO Year
  • ICUI 1992
  • GFF N/A
  • Fundamental
  • Price
  • ICUI $129.10
  • GFF $75.73
  • Analyst Decision
  • ICUI Buy
  • GFF Strong Buy
  • Analyst Count
  • ICUI 6
  • GFF 4
  • Target Price
  • ICUI $186.60
  • GFF $99.00
  • AVG Volume (30 Days)
  • ICUI 269.3K
  • GFF 341.8K
  • Earning Date
  • ICUI 11-11-2025
  • GFF 11-12-2025
  • Dividend Yield
  • ICUI N/A
  • GFF 0.95%
  • EPS Growth
  • ICUI N/A
  • GFF N/A
  • EPS
  • ICUI N/A
  • GFF 1.49
  • Revenue
  • ICUI $2,372,504,000.00
  • GFF $2,517,417,000.00
  • Revenue This Year
  • ICUI N/A
  • GFF N/A
  • Revenue Next Year
  • ICUI N/A
  • GFF $2.03
  • P/E Ratio
  • ICUI N/A
  • GFF $50.90
  • Revenue Growth
  • ICUI 2.96
  • GFF N/A
  • 52 Week Low
  • ICUI $107.00
  • GFF $62.26
  • 52 Week High
  • ICUI $196.26
  • GFF $86.73
  • Technical
  • Relative Strength Index (RSI)
  • ICUI 51.94
  • GFF 46.01
  • Support Level
  • ICUI $121.61
  • GFF $78.08
  • Resistance Level
  • ICUI $136.61
  • GFF $80.34
  • Average True Range (ATR)
  • ICUI 4.03
  • GFF 2.11
  • MACD
  • ICUI 0.24
  • GFF -0.20
  • Stochastic Oscillator
  • ICUI 49.93
  • GFF 9.88

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

About GFF Griffon Corporation

Griffon Corp manufactures and markets residential, commercial and industrial garage doors to professional installing dealers and home center retail chains. It also provides non-powered landscaping products for homeowners and professionals. Its operating segments include Consumer and Professional Products: is a provider of branded consumer and professional tools; residential, industrial and commercial fans; home storage and organization products; and Home and Building Products conducts its operations through Clopay Corporation (Clopay). Clopay is the manufacturer and marketer of garage doors and rolling steel doors in North America. The company generates a majority of its revenue from the Home and Building Products segment. Operates in USA, Europe, Canada, Australia, and Others.

Share on Social Networks: